Osteoporosis and fractures in systemic lupus erythematosus

Arthritis Care and Research

Volumn 64, Issue 1, 2012, Pages 2-8

  Bultink, Irene E M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; COLLAGEN; COMPLEMENT COMPONENT C4; ESTRADIOL; HYDROXYCHLOROQUINE; OSTEOCLAST DIFFERENTIATION FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE[1-34]; PRASTERONE; RISEDRONIC ACID; SUNSCREEN; TESTOSTERONE; TUMOR NECROSIS FACTOR; ZOLEDRONIC ACID;

AGE DISTRIBUTION; ALCOHOL ABUSE; ARTICLE; BODY MASS; BODY WEIGHT; CALCIUM INTAKE; COMPLEMENT BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FRACTURE; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY FAILURE; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; SEX DIFFERENCE; SKIN PIGMENTATION; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY;

BONE AND BONES; BONE DENSITY; BONE REMODELING; FRACTURES, BONE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOPOROSIS; PROGNOSIS; RISK FACTORS;

EID: 84856884877     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20568     Document Type: Article

References (63)

1. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabec-ular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34. (Pubitemid 23360013)
2. Mok CC, Mak A, Ma KM. Bone mineral density in postmeno-pausal Chinese patients with systemic lupus erythematosus. Lupus 2005;14:106-12. (Pubitemid 40327660)
3. Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 2003;22:318-23. (Pubitemid 37483628)
4. Uaratanawong S, Deesomchoke U, Lertmaharit S, Uara-tanawong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 2003;30: 2365-8. (Pubitemid 37413894)
5. Almehed K, Forsblad DH, Kvist G, Ohlsson C, Carlsten H. Prevalence and risk factors of osteoporosis in female SLE patients: extended report. Rheumatology (Oxford) 2007;46: 1185-90. (Pubitemid 47050627)
6. Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum 2004;50:3591-5. (Pubitemid 39488684)
7. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 1995;8:137-45.
8. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus ery-thematosus. Arthritis Rheum 2005;54:2044-50. (Pubitemid 40994328)
9. Kipen Y, Strauss BJ, Morand EF. Body composition in systemic lupus erythematosus. Br J Rheumatol 1998;37:514-9.
10. Mok CC, Ying SK, To CH, Ma KM. Bone mineral density and body composition in men with systemic lupus erythe-matosus: a case control study. Bone 2008;43:327-31.
11. Ettinger B, Sidney S, Cummings SR, Libanati C, Bikle DD, Tekawa IS, et al. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab 1997;82:429-34. (Pubitemid 27068606)
12. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8. (Pubitemid 32062031)
13. Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005;64:111-3. (Pubitemid 40075285)
14. Lee C, Almagor O, Dunlop DD, Chadha AB, Manzi S, Spies S, et al. Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus. Arthritis Rheum 2007;57:585-92. (Pubitemid 46764047)
15. Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Ra-himah I, et al. A comparison of calcium, calcitriol, and alen-dronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol 2008;35: 2344-7.
16. Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Es-carcega RO, Jimenez-Hernandez M, Etchegaray-Morales I, et al. Risks factors for low bone mineral density in pre-meno-pausal Mexican women with systemic lupus erythematosus. Clin Rheumatol 2009;28:65-70.
17. Fangtham M, Petri M. Predictors of osteoporotic fracture in SLE abstract. Arthritis Rheum 2009;60 Suppl:S110.
18. Rhew EY, Lee C, Eksarko P, Dyer AR, Tily H, Spies S, et al. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. J Rheumatol 2008;35:230-6. (Pubitemid 351281143)
19. Svenungsson E, Fei GZ, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J. TNF-α: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 2003;12:454-61. (Pubitemid 36830119)
20. Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005;52:192-200. (Pubitemid 40129248)
21. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-/3/BMP signaling pathways. Aging Cell 2004;3:379-89. (Pubitemid 40246708)
22. Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 1999; 18:137-40.
23. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB, et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 2006; 45:53-60. (Pubitemid 43033875)
24. Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Mu-noz-Guarneros M, Escarcega RO, Jimenez-Hernandez M, et al. Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 2009;28:579-85.
25. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999;10:413-24. (Pubitemid 29068083)
26. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-62. (Pubitemid 26128323)
27. Zhu K, Beilby J, Dick IM, Devine A, Soos M, Prince RL. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 2009; 20:1183-91.
28. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009;20: 427-33.
29. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28: 2535-9. (Pubitemid 33031987)
30. Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13-9.
31. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus ery-thematosus. Autoimmun Rev 2006;5:114-7. (Pubitemid 43129539)
32. Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hy-droxyvitamin D: a preliminary study. Arch Dermatol 1988; 124:1802-4. (Pubitemid 19010098)
33. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Ber-riotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008;47:920-3. (Pubitemid 351796385)
34. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010;62:1160-5.
35. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 2007;1109:550-7. (Pubitemid 47511398)
36. Garcia-Carrasco M, Mendoza-Pinto C, Escarcega RO, Jimenez-Hernandez M, Etchegaray Morales I, Munguia Realpozo P, et al. Osteoporosis in patients with systemic lupus erythemato-sus. Isr Med Assoc J 2009;11:486-91.
37. Formiga F, Moga I, Nolla JM, Navarro MA, Bonnin R, Roig-Escofet D. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:387-92. (Pubitemid 27324000)
38. Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Horslev-Petersen K, Hyldstrup L, et al. Bone metabolism in patients with systemic lupus erythematosus: effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 1998;27:197-206. (Pubitemid 28267112)
39. Jardinet D, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau FA. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford) 2000;39:389-92. (Pubitemid 30307324)
40. Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E. Three year followup of bone mineral density change in pre-menopausal women with systemic lupus erythematosus. J Rheumatol 1999;26:310-7. (Pubitemid 29066734)
41. Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
42. Ramsey-Goldman R, Dunn JE, Huang CF, Dunlop D, Rairie JE, Fitzgerald S, et al. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 1999;42:882-90. (Pubitemid 29214998)
43. Weiss RJ, Wick MC, Ackermann PW, Montgomery SM. Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases: a case-control study with 53,108 patients with fracture. J Rheumatol 2010;37:2247-50.
44. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey-Goldman R. Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol 2007;34:2018-23. (Pubitemid 47548204)
45. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corti-costeroids. Arthritis Rheum 2000;43:1801-8. (Pubitemid 30642567)
46. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-7.
47. Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 2000;15:1384-92. (Pubitemid 30413872)
48. Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis study. Osteoporos Int 2003;14:61-8. (Pubitemid 36267902)
49. Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 2005;14:529-33. (Pubitemid 41161084)
50. Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, et al. High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 2009;36:1646-52.
51. Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003;18:1947-54. (Pubitemid 37377443)
52. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocor-ticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010;62:1515-26.
53. Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 2007;22:1668-71. (Pubitemid 351235133)
54. Den Uyl D, Bultink IE, Lems WF. Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2011;13:233-40.
55. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borg-strom F, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteopo-ros Int 2008;19:399-428.
56. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999;60: 68-73. (Pubitemid 29397194)
57. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsen-berg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-91. (Pubitemid 351229318)
58. O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, et al. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg 2009;67:1363-72.
59. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010;25:2267-94.
60. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-62.
61. Mok CC, To CH, Mak A, Ma KM. Raloxifene for postmeno-pausal women with systemic lupus erythematosus: a pilot randomized controlled study. Arthritis Rheum 2005;52:3997-4002. (Pubitemid 41798239)
62. Sanchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, et al. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol 2008;35:1567-75.
63. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009;61:370-7.